{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:22:10Z","timestamp":1784067730952,"version":"3.55.0"},"reference-count":39,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"unspecified","delay-in-days":219,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Pall Supp Care"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:sec id=\"S1478951525100461_sec1a\">\n\t    <jats:title>Objectives<\/jats:title>\n\t    <jats:p>Cancer patients often suffer from refractory symptoms near death. The use of sedatives aims to relieve suffering caused by these symptoms. The practice varies broadly. The aim of this study was to evaluate the role and trends of midazolam use in cancer patients dying in a university hospital oncology ward.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S1478951525100461_sec2b\">\n\t    <jats:title>Methods<\/jats:title>\n\t    <jats:p>The study population of this retrospective registry-based study consists of patients who died in a university hospital oncology ward in Eastern Finland in 2010\u20132018 (n = 639). Information about treatment decisions, midazolam use, and background factors were gathered.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S1478951525100461_sec3c\">\n\t    <jats:title>Results<\/jats:title>\n\t    <jats:p>During the study period, 14.7 % of the patients dying in the ward received midazolam with sedative intent prior to death. 4.7 % (n = 30) of the whole study population had continuous infusion and the rest of the midazolam use was one or multiple single doses. Documented discussion of possible palliative sedation (PS) use was found in almost one third of all patients. Out of those, eventually receiving midazolam with sedative intent, two thirds had had this discussion. The most common symptoms leading to midazolam were dyspnea, pain, and delirium. In continuous use the median midazolam infusion rate was 4.0 mg\/h. The continuous infusion started median of 23.25 h and multiple single doses 19 h before death. If only one dose of midazolam was needed, it was given median of 30 minutes prior to death and the most common symptom was dyspnea. Those who received midazolam were more likely to be younger (<jats:italic>p = 0.003<\/jats:italic>) and had had a palliative outpatient clinic visit (<jats:italic>p = 0.045<\/jats:italic>).<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S1478951525100461_sec4d\">\n\t    <jats:title>Significance of results<\/jats:title>\n\t    <jats:p>This is the first study to report the trends and practices of midazolam use for refractory symptoms in Finland. Midazolam was used for approximately every 7<jats:sup>th<\/jats:sup> dying cancer patient. Applying midazolam was supported by a history of palliative clinic visits and younger age.<\/jats:p>\n\t  <\/jats:sec>","DOI":"10.1017\/s1478951525100461","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T02:04:17Z","timestamp":1754618657000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":1,"title":["Refractory symptoms and end of life midazolam use in cancer patients, a single center experience"],"prefix":"10.1017","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5292-676X","authenticated-orcid":false,"given":"Anna-Maria","family":"Tolppanen","sequence":"first","affiliation":[{"name":"The Wellbeing Services County of North Savo"},{"name":"University of Eastern Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamarja","family":"Lamminm\u00e4ki","sequence":"additional","affiliation":[{"name":"The Wellbeing Services County of North Savo"},{"name":"University of Eastern Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enni","family":"J\u00e4rvenp\u00e4\u00e4","sequence":"additional","affiliation":[{"name":"Wellbeing Services County of Central Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa","family":"Kataja","sequence":"additional","affiliation":[{"name":"Wellbeing Services County of South Savo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina","family":"Tyynel\u00e4-Korhonen","sequence":"additional","affiliation":[{"name":"P\u00e4ij\u00e4t-H\u00e4me Wellbeing Services County"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"S1478951525100461_ref7","first-page":"555","article-title":"Medical End-of-Life Practices in Switzerland: a Comparison of 2001 and 2013","volume":"176","author":"Bosshard","year":"2016","journal-title":"Journal of the American Medical Association"},{"key":"S1478951525100461_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00401-5"},{"key":"S1478951525100461_ref32","first-page":"50","article-title":"Sedation at the end of life - a nation-wide study in palliative care units in Austria","volume":"15","author":"Schur","year":"2016","journal-title":"BioMed Central Palliative Care"},{"key":"S1478951525100461_ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2461-1"},{"key":"S1478951525100461_ref37","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2022.2063068"},{"key":"S1478951525100461_ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-008-0459-4"},{"key":"S1478951525100461_ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06730-8"},{"key":"S1478951525100461_ref20","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.13019"},{"key":"S1478951525100461_ref33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2107138"},{"key":"S1478951525100461_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2020.09.022"},{"key":"S1478951525100461_ref28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jpainsymman.2016.05.008","article-title":"Level of Discomfort Decreases After the Administration of Continuous Palliative Sedation: a Prospective Multicenter Study in Hospices and Palliative Care Units","volume":"52","author":"RHPD","year":"2016a","journal-title":"Journal of Pain and Symptom Management"},{"key":"S1478951525100461_ref5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25681"},{"key":"S1478951525100461_ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-4011-2"},{"key":"S1478951525100461_ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3722-8"},{"key":"S1478951525100461_ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-011-1217-6"},{"key":"S1478951525100461_ref11","first-page":"581","article-title":"European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care","volume":"23","author":"Cherny","year":"2009","journal-title":"and"},{"key":"S1478951525100461_ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1049909114533002"},{"key":"S1478951525100461_ref22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.3795"},{"key":"S1478951525100461_ref10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu238"},{"key":"S1478951525100461_ref34","unstructured":"Statement on Palliative Sedation Approved by the AAHPM Board of Directors on December 5, 2014. https:\/\/aahpm.org\/positions\/palliative-sedation Accessed February 1, 2025."},{"key":"S1478951525100461_ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2015.12.327"},{"key":"S1478951525100461_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(97)00263-7"},{"key":"S1478951525100461_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.06.012"},{"key":"S1478951525100461_ref31","first-page":"373","article-title":"Sedatives and sedation at the end of life in the hospital\u2014a multicenter retrospective cohort study","volume":"119","author":"Schildmann","year":"2022","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"S1478951525100461_ref8","first-page":"17","article-title":"The Richmond Agitation-Sedation Scale modified for palliative care inpatients (RASS-PAL): a pilot study exploring validity and feasibility in clinical practice","volume":"13","author":"Bush","year":"2014","journal-title":"BioMed Central Palliative Care"},{"key":"S1478951525100461_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2011.07.007"},{"key":"S1478951525100461_ref26","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2019.0606"},{"key":"S1478951525100461_ref35","doi-asserted-by":"publisher","DOI":"10.1136\/spcare-2022-004085"},{"key":"S1478951525100461_ref6","first-page":"1","article-title":"Palliative pharmacological sedation for terminally ill adults","volume":"2015","author":"Beller","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"S1478951525100461_ref13","doi-asserted-by":"publisher","DOI":"10.1177\/02692163211022943"},{"key":"S1478951525100461_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2020.103859"},{"key":"S1478951525100461_ref27","first-page":"13","article-title":"Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center","volume":"17","author":"Prado","year":"2018","journal-title":"BioMed Central Palliative Care"},{"key":"S1478951525100461_ref15","first-page":"951","article-title":"Palliative Sedation for the Terminally Ill Patient","volume":"32","author":"Garetto","year":"2018","journal-title":"Central Nervous System"},{"key":"S1478951525100461_ref18","first-page":"54","article-title":"Medical end-of-life practices in Swiss cultural regions: a death certificate study","volume":"16","author":"Hurst","year":"2018","journal-title":"Bone Marrow Concentrate Medicine"},{"key":"S1478951525100461_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2005.07.004"},{"key":"S1478951525100461_ref23","doi-asserted-by":"publisher","DOI":"10.1177\/107327481502200409"},{"key":"S1478951525100461_ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2016-001159"},{"key":"S1478951525100461_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2006.10.015"},{"key":"S1478951525100461_ref30","unstructured":"The role of Palliative Sedation in palliative care . eBook edited by Ian Koper, Jeroen Hasselaar and Cathy Payne (2024). https:\/\/www.palliativesedation.eu\/ Accessed February 1, 2025."}],"container-title":["Palliative and Supportive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1478951525100461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T10:57:00Z","timestamp":1755082620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1478951525100461\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":39,"alternative-id":["S1478951525100461"],"URL":"https:\/\/doi.org\/10.1017\/s1478951525100461","relation":{},"ISSN":["1478-9515","1478-9523"],"issn-type":[{"value":"1478-9515","type":"print"},{"value":"1478-9523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press.","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e138"}}